AEPFX
Price
$60.57
Change
+$0.04 (+0.07%)
Updated
Jul 18 closing price
Net Assets
133.7B
FDKFX
Price
$15.58
Change
-$0.07 (-0.45%)
Updated
Jul 18 closing price
Net Assets
590.61M
Interact to see
Advertisement

AEPFX vs FDKFX

Header iconAEPFX vs FDKFX Comparison
Open Charts AEPFX vs FDKFXBanner chart's image
American Funds EUPAC F2
Price$60.57
Change+$0.04 (+0.07%)
VolumeN/A
Net Assets133.7B
Fidelity International Discovery K6
Price$15.58
Change-$0.07 (-0.45%)
VolumeN/A
Net Assets590.61M
AEPFX vs FDKFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPFX vs. FDKFX commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPFX is a Buy and FDKFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPFX has more cash in the bank: 134B vs. FDKFX (591M). FDKFX pays higher dividends than AEPFX: FDKFX (3.38) vs AEPFX (0.87). AEPFX was incepted earlier than FDKFX: AEPFX (17 years) vs FDKFX (6 years). FDKFX (0.60) and AEPFX (0.58) have similar cost to investors . FDKFX is a more actively managed with annual turnover of: 48.00 vs. AEPFX (35.00). FDKFX has a lower initial minimum investment than AEPFX: FDKFX (0) vs AEPFX (250). FDKFX annual gain was more profitable for investors over the last year : 14.54 vs. AEPFX (4.41). FDKFX return over 5 years is better than : 51.71 vs. AEPFX (17.00).
AEPFXFDKFXAEPFX / FDKFX
Total Expense Ratio0.580.6097%
Annual Report Gross Expense Ratio0.580.6097%
Fund Existence17 years6 years-
Gain YTD13.01319.46667%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets134B591M22,673%
Annual Yield % from dividends0.873.3826%
Returns for 1 year4.4114.5430%
Returns for 3 years32.9957.1258%
Returns for 5 years17.0051.7133%
Returns for 10 years30.48N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRL156.701.76
+1.14%
Charles River Laboratories International
RARE27.410.10
+0.37%
Ultragenyx Pharmaceutical
CRBP8.52N/A
N/A
Corbus Pharmaceuticals Holdings
TYRA10.86-0.06
-0.55%
Tyra Biosciences
BOXL2.39-0.12
-4.78%
Boxlight Corporation